Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	Phase 1: Dose Finding	7
Overall Study	STARTED	Phase 2: Arm A Alkylator-resistant	15
Overall Study	STARTED	Phase 2: Arm B NOT Alkylator-resistant	24
Overall Study	STARTED	GBM Arm	10
Overall Study	STARTED	Surgical Arm	10
Overall Study	COMPLETED	Phase 1: Dose Finding	7
Overall Study	COMPLETED	Phase 2: Arm A Alkylator-resistant	15
Overall Study	COMPLETED	Phase 2: Arm B NOT Alkylator-resistant	24
Overall Study	COMPLETED	GBM Arm	10
Overall Study	COMPLETED	Surgical Arm	10
Overall Study	NOT COMPLETED	Phase 1: Dose Finding	0
Overall Study	NOT COMPLETED	Phase 2: Arm A Alkylator-resistant	0
Overall Study	NOT COMPLETED	Phase 2: Arm B NOT Alkylator-resistant	0
Overall Study	NOT COMPLETED	GBM Arm	0
Overall Study	NOT COMPLETED	Surgical Arm	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03914742/flow